CLINICAL INNOVATION ApS: Financial statements 2017
CVR: 29924880
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
CLINICAL INNOVATION ApS (CVR 29924880) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 3,721,000 and a net result of DKK 243,000 compared with DKK 754,000 the year before. That is a decrease of 5.1% compared with the year before. Equity in the 2017 report amounted to DKK 3,013,000. The solvency ratio was 39.3%. The company had 7,000 employees in the financial year.
- Gross Profit
- DKK 3,721,000
- Profit/Loss
- DKK 243,000
- Equity
- DKK 3,013,000
- Total Assets
- DKK 7,664,000
- Employees
- 7,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 3.7 mio. | 243 t. | 3 mio. | 7000 |
| 2016 | - | 3.9 mio. | 754 t. | 2.9 mio. | 6000 |
| 2015 | - | 3.2 mio. | 272 t. | 3.1 mio. | - |
| 2014 | - | 2.8 mio. | 483 t. | 2.9 mio. | - |
| 2013 | - | 3 mio. | 545 t. | 2.6 mio. | - |
Official annual report
Keep an eye on CLINICAL INNOVATION ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of November 7, 2017, PIA & CLAUS DINESEN HOLDING ApS is registered as an owner of CLINICAL INNOVATION ApS with an ownership share of 100%.
CLINICAL INNOVATION ApS has published its annual report for 2016. Gross profit came to DKK 3,923,000, and the net result was DKK 754,000.
About CLINICAL INNOVATION ApS
CLINICAL INNOVATION ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Claus Michael Dinesen. The board consists of Ole Hedemann (chair), Claus Michael Dinesen, Magnus Oliver Lorentzen Dinesen and Marc Phillip Gall Schultz Lorentzen. The company is owned by PIA & CLAUS DINESEN HOLDING ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 2,775,826 and a net result of DKK 413,835 compared with DKK 95,746 the year before. Equity in the 2025 report amounted to DKK 3,821,950.